Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis Provided by GlobeNewswire Jul 9, 2025, 11:00:00 AM ...

Eye drop administration of KB801 designed to enable sustained expression of NGF in the front of the eye Investor call and webcast to be held July 9 at 8:30 am ET to discuss program and trial design ...

BRITS have been warned eyedrops used as a hayfever remedy have been recalled over risk of serious infection. Retailers have been advised to “stop supplying” the affected batch “im… ...

The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis (AK), an ultra-rare parasitic infection that can lead to blindness.

“Our ophthalmology pipeline is well under way with the dosing of our first patient in EMERALD-1, along with initiation of our Phase 3 IOLITE study in DEB,” said Suma Krishnan, President ...

Extension specialists share tips to help producers deal with pinkeye’s contagious nature and the damage it can cause to a cow herd’s performance and productivity.

BACKGROUND/AIMS Chemokines are small peptides which are potent activators and chemoattractants for leucocyte subpopulations. Their action is mediated by a family of seven transmembrane spanning ...

The incidence of corneal blindness caused by microbial keratitis in the developing world is far higher than that in the developed world.1 Microbial keratitis has become a more prominent cause of ...